Bioengineering in an Era of AI: Papers from The 2nd International Conference on Bioengineering (BIOENG-2026)
This special issue belongs to the section "Biosignal Processing".
Special Issue Information
Dear Colleagues,
Bioengineering is a rapidly evolving discipline positioned at the convergence of the biological, physical, computational, and engineering sciences. Advances in artificial intelligence (AI), machine learning, and data-driven methods are accelerating this evolution, providing powerful new approaches for understanding and engineering complex biological systems across scales—from molecules and cells to tissues, organisms, populations, and healthcare systems.
The 2nd International Conference on Bioengineering (BIOENG-2026) is organized around the theme “Bioengineering in an Era of AI”. While this theme provides a timely framework for the conference, BIOENG-2026 embraces the breadth of contemporary bioengineering, and contributions are welcome across the full spectrum of the discipline.
Plenary lectures bring the conference community together around perspectives from internationally recognized leaders, while keynote presentations anchor the scientific sessions. Scientists, engineers, clinicians, innovators, and technologists from around the world convene to address consequential challenges in health, healthcare, human performance, and the bioeconomy through fundamental discovery, technological innovation, and convergent approaches. Topics range from intelligent medical systems, bioinstrumentation, biomaterials, and regenerative engineering to computational modeling, biomechanics, bioprocessing, molecular and cellular engineering, and precision health technologies.
The theme “Bioengineering in an Era of AI” recognizes both the transformative opportunities and the emerging challenges that AI presents for the discipline. Generative AI and foundation models are expanding beyond their early applications in language and image generation to influence protein and biomolecular design, synthetic biology, biomaterials discovery, and therapeutic development. Deep neural networks and other machine-learning approaches increasingly provide the computational framework for interrogating high-dimensional biological datasets, including structural biology and multi-omics data. In biomedical imaging, computer vision and AI-assisted analysis are advancing tissue segmentation, three-dimensional reconstruction, quantitative phenotyping, and the detection and classification of pathological features. Multimodal AI further enables the integration of clinical text, physiological signals, medical images, molecular measurements, and other heterogeneous data into unified predictive frameworks supporting patient stratification, precision healthcare, predictive analytics, and emerging digital-twin approaches.
These advances also raise important scientific and translational questions concerning validation, reproducibility, interpretability, bias, data provenance, privacy, regulatory oversight, and the appropriate relationship between human expertise and machine intelligence. BIOENG-2026 therefore considers AI not simply as another computational tool, but as an increasingly important element of the changing intellectual and technological landscape within which bioengineering is practiced.
This Special Issue of Bioengineering will bring together full-length scholarly articles arising from work presented at BIOENG-2026. It is important to emphasize that these contributions are not conference proceedings papers. Submitted manuscripts must constitute complete journal articles, will undergo the journal's standard peer-review process, and must meet the scientific, methodological, and editorial standards of Bioengineering. Both research articles and other article types appropriate to the journal are welcomed, consistent with its scope.
The scientific program of BIOENG-2026 comprises three topical symposia and six disciplinary tracks:
Topical Symposia
- SYMP.1 — Perspectives on Aging.
- SYMP.2 — WearTech for Sports and Health.
- SYMP.3 — BioInnovation to Commercialization.
Scientific Tracks
- S1 — Regenerative Engineering.
- S2 — Biochemical Engineering.
- S3 — Biosignal Processing.
- S4 — Biomedical Engineering and Biomaterials.
- S5 — Biomechanics and Sports Medicine.
- S6 — Cellular and Molecular Bioengineering.
Together, these areas reflect both the disciplinary breadth of modern bioengineering and its increasingly convergent character. We invite conference participants to develop the work presented at BIOENG-2026 into rigorous, substantive articles that capture not only advances in bioengineering science and technology, but also the new possibilities emerging as the discipline enters an era increasingly shaped by artificial intelligence.
Prof. Dr. Anthony Guiseppi-Elie
Dr. Rossana Madrid
Prof. Dr. Liang Luo
Prof. Dr. X. Nancy Xu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- bioengineering
- stem cells
- regenerative engineering
- scaffolds
- biomaterials
- bioreactors
- biochemical engineering
- bioprocess optimization
- biosignals
- biomedical imaging
- medical devices
- biomechanics
- wearable technologies
- sports medicine
- human performance
- biomolecular engineering
- cellular engineering
- cellular microenvironment
- precision health
- machine learning
- multimodal AI
- digital twins
- bioinnovation
- commercialization
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

